Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus

European Journal of Human Genetics

Volumn 18, Issue 9, 2010, Pages 1027-1031

  Morris, David L ^a   Roberts, Amy L ^a   Witherden, Abigail S ^a   Tarzi, Ruth ^b   Barros, Paula ^a   Whittaker, John C ^c   Cook, Terence H ^b   Aitman, Timothy J ^a   Vyse, Timothy J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

CNV; FCGR3B; genetics; NA1 NA2; systemic lupus erythematosus

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIIB; UNCLASSIFIED DRUG;

ADULT; ALLELE; ALLOTYPE; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; GPI-LINKED PROTEINS; HUMANS; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECEPTORS, IGG; RISK FACTORS;

EID: 77955981761     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2010.56     Document Type: Article

References (35)

1. Rhodes B, Vyse TJ: General aspects of the genetics of SLE. Autoimmunity 2007; 40: 550-559.
2. Vyse TJ: Understanding lupus: fishing genes out of mice and men. Immunity 2008; 28: 8-10.
3. Criswell LA: The genetic contribution to systemic lupus erythematosus. Bull NYU Hosp Jt Dis 2008; 66: 176-183.
4. Fanciulli M, Norsworthy PJ, Petretto E et al: FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007; 39: 721-723.
5. Shaw-Smith C, Redon R, Rickman L et al: Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet 2004; 41: 241-248.
6. Iafrate AJ, Feuk L, Rivera MN et al: Detection of large-scale variation in the human genome. Nat Genet 2004; 36: 949-951.
7. Sebat J, Lakshmi B, Troge J et al: Large-scale copy number polymorphism in the human genome. Science 2004; 305: 525-528.
8. Fanciulli M, Petretto E, Aitman TJ: Gene copy number variation and common human disease. Clin Genet 2009; 77: 201-213.
9. Urban TJ, Weintrob AC, Fellay J et al: CCL3L1 and HIV/AIDS susceptibility. Nat Med 2009; 15: 1110-1112.
10. Field SF, Howson JMM, Maier LM et al: Experimental aspects of copy number variant assays at CCL3L1. Nat Med 2009; 15: 1115-1117.
11. Gonzalez E, Kulkarni H, Bolivar H et al: The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307: 1434-1440.
12. Yang Y, Chung EK, Wu YL et al: Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 2007; 80: 1037-1054.
13. Willcocks LC, Lyons PA, Clatworthy MR et al: Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008; 205: 1573-1582.
14. McCarroll SA, Huett A, Kuballa P et al: Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 2008; 40: 1107-1112.
15. Breunis WB, van Mirre E, Geissler J et al: Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat 2009; 30: 640-650.
16. Karassa FB, Trikalinos TA, Ioannidis JP: Fc gamma RIIIA-SLE meta-analysis investigators. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int 2003; 63: 1475-1482.
17. Kono H, Kyogoku C, Suzuki T et al: FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 2005; 14: 2881-2892.
18. Floto RA, Clatworthy MR, Heilbronn KR et al: Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 2005; 11: 1056-1058.
19. Brown EE, Edberg JC, Kimberly RP: Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity 2007; 40: 567-581.
20. Yap SN, Phipps ME, Manivasagar M, Bosco JJ: Fc gamma receptor IIIB-NA gene frequencies in patients with systemic lupus erythematosus and healthy individuals of Malay and Chinese ethnicity. Immunol Lett 1999; 68: 295-300.
21. Hatta Y, Tsuchiya N, Ohashi J et al: Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun 1999; 1: 53-60.
22. González-Escribano MF, Aguilar F, Sánchez-Román J, Núñez-Roldán A: FcgammaRIIA, FcgammaRIIIA and FcgammaRIIIB polymorphisms in Spanish patients with systemic lupus erythematosus. Eur J Immunogenet 2002; 29: 301-306.
23. Cukier HN, Pericak-Vance MA, Gilbert JR, Hedges DJ: Sample degradation leads to false-positive copy number variation calls in multiplex real-time polymerase chain reaction assays. Anal Biochem 2009; 386: 288-290.
24. Hollox EJ, Detering J-C, Dehnugara T: An integrated approach for measuring copy number variation at the FCGR3B (CD16) locus. Hum Mut 2009; 30: 477-484.
25. Walker S, Janyakhantikul S, Armour JAL: Multiplex paralogue ratio tests for accurate measurement of multiallelic CNVs. Genomics 2009; 93: 98-103.
26. Karassa FB, Trikalinos TA, Ioannidis JP: Fc gamma RIIIA-SLE meta-analysis investigators. The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int 2003; 63: 1475-1482.
27. Tan EM, Cohen AS, Fries JF et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
28. Zhou P, Comenzo RL, Olshen AB et al: CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy. Blood 2008; 111: 3403-3406.
29. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
30. Lehmann EL: Testing Statistical Hypotheses, 2nd edn. New York: John Wiley and Sons, 1986.
31. Roberton CA, Morley BJ, Vyse TJ: Fine mapping genes for Fc gamma receptor II and III in systemic lupus erythematosus. Am J Hum Genet 2001; 69: 568.
32. Kono H, Kyogoku C, Suzuki T et al: FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 2005; 14: 2881-2892.
33. Salmon JE, Edberg JC, Kimberly RP: Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest 1990; 85: 1287-1295.
34. Lee YH, Ji JD, Song GG: Fcg receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Lupus 2009; 18: 727-734.
35. Bredius RG, Fijen CA, De Haas M: Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1 and IgG3-opsonized bacteria erythrocytes. Immunology 1994; 83: 624-630.